Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol

At Complete Neurological Care, we blend compassionate care with the most advanced tools in neuroscience including peptide therapy
The hypothesis is that the fundamental healing mechanisms BPC-157 promotesangiogenesis, collagen synthesis, anti-inflammationare universal and would therefore apply to the damaged annulus fibrosus of a disc
Glutathione may also help manage symptoms of autoimmune diseases and psoriasis by reducing oxidative stress and inflammation
Lavender oil calms, balances, and boosts radiant skin
Extraintestinal roles of bombesin-like peptides and their receptors: Lung